JPMorgan Chase & Co. Increases Stock Position in Akero Therapeutics, Inc. (NASDAQ:AKRO)
JPMorgan Chase & Co. grew its holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 8.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 528,207 shares of the company’s stock after purchasing an additional 40,161 shares during the quarter. JPMorgan […]
JPMorgan Chase & Co. grew its holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 8.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 528,207 shares of the company’s stock after purchasing an additional 40,161 shares during the quarter. JPMorgan […]
